Brazil regulator says documents still missing for fast-track COVID-19 vaccine approval

15 Jan 2021 / 01:18 H.

    BRASILIA, Jan 14 (Reuters) - Brazil's health regulator Anvisa said on Thursday that it still requires further documentation before it can approve emergency use requests for COVID-19 vaccines developed by AstraZeneca PLC and China Sinovac Biotech.

    Anvisa has scheduled a meeting on Sunday to decide on the fast-track approvals that would allow vaccination to get under way in Brazil next week. (Reporting by Anthony Boadle)

    email blast